Journal Article Research Support, Non-U.S. Gov't Epublish 20 citations
PubMed: 35372107 DOI: 10.3389/fcimb.2022.831186
Gut Microbiota-Related Inflammation Factors as a Potential Biomarker for Diagnosing Major Depressive Disorder.
Front Cell Infect Microbiol 12:831186
Authors: Shunjie Bai, Huili Bai, Detao Li, Qi Zhong, Jing Xie, Jian-Jun Chen
Affiliations
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
- Chongqing Emergency Medical Center, Department of Endocrinology, The Fourth People's Hospital of Chongqing, Central Hospital of Chongqing University, Chongqing, China.
Abstract
Objective
Although many works have been done, the objectively measured diagnostic biomarkers are not available. Thus, we conducted this study to identify potential biomarkers for objectively diagnosing depression and explore the role of gut microbiota in the onset of depression.
Methods
Major depressive disorder (MDD) patients (n=56) and demographic data-matched healthy controls (HCs) (n=56) were included in this study. The gut microbiota in fecal samples and inflammation-related factors in serum were measured. Both univariate and multivariate statistical analyses were performed to identify the differential gut microbiota and inflammation-related factors.
Results
Finally, 46 differential operational taxonomic units (OTUs) (60.9% OTUs belonging to Firmicutes) and ten differential inflammation-related factors were identified. Correlation analysis showed that there were significant correlations between 14 differential OTUs (9 OTUs belonging to Firmicutes and 5 OTUs belonging to family Lachnospiraceae under Firmicutes) and seven differential inflammation-related factors. Meanwhile, 14 differential OTUs (9 OTUs belonging to Firmicutes and 5 OTUs belonging to family Lachnospiraceae under Firmicutes) and five differential inflammation-related factors (adiponectin, apolipoprotein A1, alpha 1-antitrypsin, neutrophilicgranulocyte count/white blood cell count and basophil count) were significantly correlated to depression severity. A panel consisting of these five differential inflammation-related factors could effectively diagnose MDD patients from HCs.
Conclusions
Our results suggested that Firmicutes, especially family Lachnospiraceae, might play a role in the onset of depression affecting the inflammation levels of host, and these five differential inflammation-related factors could be potential biomarkers for objectively diagnosing MDD.
MeSH
Depression, Biomarkers, Depressive Disorder, Cell Biology, Gastrointestinal Microbiome, Microbiota, Depressive Disorder, Major
Cited by
- Unraveling the Metabolic and Microbiome Signatures in Fecal Samples of Pregnant Women with Prenatal Depression. Metabolites, 2025
- Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile. BMC Psychiatry, 2024
- Leaky Gut Biomarkers as Predictors of Depression and Suicidal Risk: A Systematic Review and Meta-Analysis. Diagnostics (Basel), 2025
- Abnormal Reginal Homogeneity in Left Anterior Cingulum Cortex and Precentral Gyrus as a Potential Neuroimaging Biomarker for First-Episode Major Depressive Disorder. Front Psychiatry, 2022
- Elevated plasma intestinal fatty acid binding protein and aberrant lipid metabolism predict post-stroke depression. Heliyon, 2022
- Neurosteroids, Microbiota, and Neuroinflammation: Mechanistic Insights and Therapeutic Perspectives. Int J Mol Sci, 2025
- Biology of cyclooxygenase-2: An application in depression therapeutics. Front Psychiatry, 2022
- Innovative strategies for post-stroke depression: integrating traditional Chinese medicine with neurobiological insights, including the gut-brain axis. Front Pharmacol, 2025
- The Interplay between Gut Microbiota and Cognitive Functioning in the Healthy Aging Population: A Systematic Review. Nutrients, 2024
- A Systematic Review on the Association between Obesity and Mood Disorders and the Role of Gut Microbiota. Metabolites, 2023
- Limosilactobacillus-related 3-OMDP as a potential therapeutic target for depression. Ann Med, 2024